Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 141
Selected: 0
NCT IDTitle
NCT04620954Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
NCT04269967A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors
NCT07111130Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
NCT06294808Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
NCT03325218Survival Expectations and Hope Among Cancer Patients at End-of-Life
NCT00471484Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
NCT00003576Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
NCT05581550Somatostatin Receptor Imaging in NPC, EBV Related Cancers
NCT06093061Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
NCT04303403Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
NCT07209501Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)
NCT04452084Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT
NCT05377034Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT04956068PIPAC for Peritoneal Metastases
NCT04014309Accessible Cancer Care to Enable Support for Survivors Programme
NCT02548039To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.
NCT00687648Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT03212807Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL
NCT07583979Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration
NCT00702481Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
NCT01865838A Study Into the Effect of Seprafilm in Open Total Thyroidectomy
NCT05148572Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma
NCT02806388Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT04087473Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
NCT01029418AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
NCT00589186Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
NCT01736410A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT01100801A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT03330509Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital
NCT02313298Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer
NCT05516628Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
NCT01228045A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT07133269Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
NCT07234357Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
NCT03792867Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NCT03430128Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC
NCT03200730A Novel Family Dignity Intervention (FDI) for Asian Palliative Care
NCT02559336Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital
NCT02804776PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
NCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT01022723Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells
NCT03515174Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO
NCT07521670Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
NCT01135056Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
NCT05773092A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
NCT02412267Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)